Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,619.43
+39.032.47%
Number of Gainers:5
Number of Losers:2
Number of Flat:- -
PE:- -
High:1,638.02
Open:1,595.38
Low:1,588.79
Close:1,580.40
Volume:57.95M
Turnover:5.23B
Market Cap:1.68T
Float Cap:1.62T

Loading ...

Pfizer is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Yesterday

BridgeBio to Present New Real-World Study Comparing Acoramidis vs Pfizer’s Tafamidis in ATTR-CM at HFSA 2026

Reuters
·
Yesterday

Health Rounds: Experimental Approach May Eliminate Cold Storage Requirement for mRNA Vaccines

Reuters
·
Yesterday

Novo Nordisk Probes Patient Priorities in German Hemophilia A Study

TIPRANKS
·
Yesterday

Scotiabank Adjusts Pfizer Price Target to $33 From $30, Sector Outperform Rating Kept

MT Newswires Live
·
Yesterday

Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race

TIPRANKS
·
Yesterday

Lilly’s New Basal Insulin Candidate Clears Key Early Trial Milestone

TIPRANKS
·
Yesterday

Moderately bullish activity in Pfizer with shares up 0.24%

TIPRANKS
·
Yesterday

General Medicine Raises $120 Mln to Build the Healthcare Store

Reuters
·
Oct 06

General Medicine - Series B Financing Led by Andreessen Horowitz (a16z), with Participation from Matrix, Vxi Capital, Eli Lilly and Company

THOMSON REUTERS
·
Oct 06

Pfizer Keeps Quarterly Dividend at $0.43 per Share, Payable Dec. 7 to Shareholders of Record as of Nov. 6

MT Newswires Live
·
Oct 06

Pfizer Declares Q4 2026 Dividend of $0.43 a Share

Reuters
·
Oct 06

Pfizer Declares Fourth-Quarter 2026 Dividend

THOMSON REUTERS
·
Oct 06

Pfizer - Declares Q4 2026 Cash Dividend of $0.43 Per Share Payable December 7, 2026

THOMSON REUTERS
·
Oct 06

Viking Therapeutics, Inc.: Reporting Results from Part 2 of Vanquish-1 Study in 2027

THOMSON REUTERS
·
Oct 06

Viking Therapeutics Announces Initiation of Vk2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

THOMSON REUTERS
·
Oct 06

NYSE Most Active Issues

Dow Jones
·
Oct 06

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

TIPRANKS
·
Oct 06

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%

TIPRANKS
·
Oct 06

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Oct 06